Effects of Atorvastatin and Aspirin on the Levels of Plasma Lysophospholipids and the Incidence of Stroke in Patients with Atrial Fibrillation
Zhan-Cai Yu,Zhen-Guang Li,Qi-Zhuan Wu,Yuan-Chen Wang,Dao-Zhen Wang,Wei-Ping Ju,Xia Zhan,Xi-Juan Wu,Li Zhou,Chao-Shu Tang
DOI: https://doi.org/10.3969/j.issn.1672-9248.2008.02.001
2008-01-01
Abstract:Objective:To observe the effect of aspirin/atorvastatin on the levels of plasma lysophosphatidic acid(LPA)or acidic phospholipids(AP)in patients with nonvalvular atrial fibrillation(NVAF).Methods:The levels of plasma LPA/AP in 169 patients with NVAF and 124 normal controls were measured and compared.All the patients with NVAF were randomly allocated to NVAF control(n=52,did not give any treatment),aspirin(n=61,100 mg/d),and aspirin plus atorvastatin(n=56,aspirin 100 mg/d and atorvastatin 10 mg/d)groups.The plasma LPA/AP levels in the three groups were measured at 3 and 12 months before and after the treatment.The occurrence of stroke was observed in all groups at 3 and 12 months.Results:The plasma LPA/AP levels in the NVAF group were 3.56±0.42 μmol/L and 6.12±0.57 U,respectively.They were significantly higher than 2.65±0.44 μmol/L and 4.68±0.45 U in the normal control group(P all < 0.01).The plasma LPA levels in the NVAF control group were 3.61±0.49,3.52±0.51,and 3.66±0.59 μmol/L respectively,and the plasma AP levels were 6.23±0.59,6.47±0.61,and 6.36±0.79 U respectively,and there were no significant difference.The plasma LAP levels in the aspirin group were 3.53±0.46,3.12±0.62 and 2.94±0.60 μmol/L respectvely,and the AP levels were 6.37±0.66,5.64±0.52 and 5.33±0.61 U,respectively.Both the levels of LPA and AP after the treatment were decreased more significantly than before the treatment(P <0.01).The plasma LPA levels in the aspirin plus atorvastatin group were 3.59±0.33,2.58±0.50,and 2.46±0.48 μmol/L respectively,and the AP levels were 6.19±0.53,4.98±0.50,and 4.64±0.58 U,respectively.Both the levels of LPA and AP after the treatment were decreased more significantly than before the treatment(P <0.01),and they were also decreased more significantly than those in the aspirin group(P <0.01).The incidence number of stroke at 3 months in the NVAF control,aspirin,and aspirin plus atorvastatin groups were 7,6,and 3 cases respectively,and they were 16,11,and 6 cases at 12 months,respectively.The aspirin,and aspirin plus atorvastatin groups were significantly less than the NVAF group(P <0.01).The aspirin plus atorvastatin group were significantly less than the aspirin group(P <0.05).Conclusions:The plasma LPA/AP levels in patients with NVAF were elevated significantly.It was suggested that platelets in vivo were in a condition of activation,and the patients with NVAF had ischemic membrane injury.Aspirin or the combination of aspirin and atorvastatin significantly decreased the occurrence of the NVAF-associated stroke.Statins can be considered during the antithrombotic therapy in patients with NVAF.